Inder Pal Singh

663 total citations
10 papers, 495 citations indexed

About

Inder Pal Singh is a scholar working on Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Inder Pal Singh has authored 10 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biochemistry, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Inder Pal Singh's work include Phytochemicals and Antioxidant Activities (4 papers), Essential Oils and Antimicrobial Activity (2 papers) and Natural Antidiabetic Agents Studies (2 papers). Inder Pal Singh is often cited by papers focused on Phytochemicals and Antioxidant Activities (4 papers), Essential Oils and Antimicrobial Activity (2 papers) and Natural Antidiabetic Agents Studies (2 papers). Inder Pal Singh collaborates with scholars based in India, United States and United Kingdom. Inder Pal Singh's co-authors include Ramesh C. Gupta, Farrukh Aqil, Jeyaprakash Jeyabalan, Radha Munagala, Hina Kausar, Ashish Kumar Agrawal, Ashley M. Mudd, Manicka V. Vadhanam, Jasmeen Sidana and Ram Jee Sharma and has published in prestigious journals such as The Lancet, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Inder Pal Singh

9 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inder Pal Singh India	6	260	175	110	76	66	10	495
Kita Valenti France	10	171 0.7×	101 0.6×	64 0.6×	150 2.0×	71 1.1×	14	524
V. Shalini India	13	223 0.9×	136 0.8×	60 0.5×	136 1.8×	63 1.0×	17	605
Nathalia da Costa Pereira Soares Brazil	9	156 0.6×	203 1.2×	51 0.5×	61 0.8×	58 0.9×	14	426
Maaike E. Schutte Netherlands	8	187 0.7×	89 0.5×	65 0.6×	89 1.2×	57 0.9×	9	500
Harini S. Aiyer United States	10	215 0.8×	210 1.2×	39 0.4×	84 1.1×	41 0.6×	20	532
Sylwia Gorlach Poland	8	200 0.8×	187 1.1×	29 0.3×	84 1.1×	68 1.0×	9	484
Ming‐Jen Fan Taiwan	15	325 1.3×	97 0.6×	46 0.4×	127 1.7×	29 0.4×	20	547
Daneida Lizárraga Netherlands	14	304 1.2×	217 1.2×	103 0.9×	72 0.9×	106 1.6×	19	697
Michael Yousef Canada	7	222 0.9×	81 0.5×	47 0.4×	66 0.9×	81 1.2×	11	467
Kanokkarn Phromnoi Thailand	13	329 1.3×	123 0.7×	57 0.5×	148 1.9×	73 1.1×	18	767

Countries citing papers authored by Inder Pal Singh

Since Specialization

Citations

This map shows the geographic impact of Inder Pal Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inder Pal Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inder Pal Singh more than expected).

Fields of papers citing papers by Inder Pal Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inder Pal Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inder Pal Singh. The network helps show where Inder Pal Singh may publish in the future.

Co-authorship network of co-authors of Inder Pal Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Inder Pal Singh. A scholar is included among the top collaborators of Inder Pal Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inder Pal Singh. Inder Pal Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Mase, Nobuyuki, et al.. (2024). Tetrahydroisoquinolines – an updated patent review for cancer treatment (2016 – present). Expert Opinion on Therapeutic Patents. 34(10). 873–906. 1 indexed citations

Singh, Inder Pal, et al.. (2023). Cataract Disease Classification using Convolutional Neural Network Architectures. 5. 992–998. 1 indexed citations

Chaudhary, Alka, et al.. (2019). Methanolic extract of Potentilla fulgens root and its ethyl-acetate fraction delays the process of carcinogenesis in mice. Scientific Reports. 9(1). 16985–16985. 8 indexed citations

Kushwah, Varun, Sameer S. Katiyar, Ashish Kumar Agrawal, et al.. (2018). Implication of linker length on cell cytotoxicity, pharmacokinetic and toxicity profile of gemcitabine-docetaxel combinatorial dual drug conjugate. International Journal of Pharmaceutics. 548(1). 357–374. 14 indexed citations

Munagala, Radha, Farrukh Aqil, Jeyaprakash Jeyabalan, et al.. (2017). Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Letters. 393. 94–102. 181 indexed citations

Aqil, Farrukh, Radha Munagala, Jeyaprakash Jeyabalan, et al.. (2012). Antioxidant and Antiproliferative Activities of Anthocyanin/Ellagitannin-Enriched Extracts FromSyzygium cuminiL. (Jamun, the Indian Blackberry). Nutrition and Cancer. 64(3). 428–438. 135 indexed citations

Kausar, Hina, Jeyaprakash Jeyabalan, Farrukh Aqil, et al.. (2012). Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Letters. 325(1). 54–62. 129 indexed citations

Singh, Inder Pal, et al.. (1997). Flavonoids and Stilbenes as Repellents against the Blue Mussel, Mytilus edulis galloprovincialis. Natural Product Sciences. 3(1). 49–54. 3 indexed citations

Mehta, SR, et al.. (1989). Falciparum malaria--present day problems. An experience with 425 cases.. PubMed. 37(4). 264–7. 23 indexed citations

10.

Singh, Inder Pal, et al.. (1961). TOLBUTAMIDE IN CIRRHOSIS OF THE LIVER. The Lancet. 278(7214). 1260–1261.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact